# Quratis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/quratis

- Industry: Biotechnology
- Headquarters: Seoul, South Korea
- Website: www.quratis.com
- Total disclosed funding: $25M
- Latest round: Series B (Aug 17, 2018)
- Investors on record: 8

## About

Founded in 2016 and based in Seoul, South Korea, Quratis Inc. is a biotechnology company that focuses on the R&D of vaccine products, cell therapy platforms, and Peptide nucleic acid (PNA) based antimicrobial agents. The company received phase 2a Investigational New Drug (IND) approval for Tuberculosis (TB) for adults in 2017, and phase 1 IND approval for TB vaccine for adolescents in 2018. And in 2019 the company performed a porcine circovirus vaccine development project and an antibiotic-resistant antimicrobial agent project. And also, the company applied phase 2b/3 IND for TB vaccine for adolescents & adults in December 2021 and was approved in July 2022. In October 2025, Wired Partners acquired 7.92 million shares in Quratis Inc. at KRW 631 apiece, for KRW 5 billion, in a PIPE deal. Following the transaction, Wired Partners will own an 11.87% minority stake in the company in total. 

The company engages in business scope including R&D of vaccines, cell-penetrating peptide technology, and peptide nucleic acid based on antimicrobial agents. The vaccines include the tuberculosis vaccine. The cell-penetrating peptide technology can be used for the R&D of antibiotics, antiviral drugs, and anticancer. The company also provides Contract Development and Manufacturing Organization (CMO & CDMO) services.

## Funding rounds

- Series B, Aug 17, 2018, $18M — AJU IB Investment, SJ Investment Partners, AG Investment, Stassets Investment, A Ventures
- Series A, Oct 27, 2017, $7.1M — Industrial Bank of Korea, Daekyo Investment, Korea Asset Investment Securities

## Investors

- Industrial Bank of Korea — Series A
- Daekyo Investment (https://capitalatlas.ai/funds/daekyo-investment) — Series A
- Korea Asset Investment Securities (https://capitalatlas.ai/funds/korea-asset-investment-securities) — Series A
- AJU IB Investment (https://capitalatlas.ai/funds/aju-ib-investment) — Series B
- SJ Investment Partners (https://capitalatlas.ai/funds/sj-investment-partners) — Series B
- AG Investment (https://capitalatlas.ai/funds/ag-investment) — Series B
- Stassets Investment (https://capitalatlas.ai/funds/stassets-investment) — Series B
- A Ventures — Series B